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Abstract The knob associated histidine-rich protein (KAHRP) 
gene was cloned and sequenced from two Indian isolates of Plas- 
modiumfalciparum, Pf3-92 and Pf29-92. These isolates howed 
major sequence differences in the C-terminal repeat domain of 
KAHRP. However, the biologically important domains such as 
spectrin-actin binding region remained highly conserved. The 
PCR amplification of a variable C-terminal repeat domain from 
the clinical isolates of P. falciparum, from Rajasthan epidemic, 
showed the presence of multiple alleles of KAHRP gene. The 
presence of multiple alleles indicates the existence of several 
P. falciparum strains in India. This should be taken into account 
for future malaria control strategies uch as molecular therapy 
and vaccines. 
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I. Introduction 
Plasmodium falciparum is responsible for the majority of 
deaths in malaria. This is because the mature parasite is able 
to sequester in brain capillaries and thereby causing cerebral 
malaria. The cerebral capillaries of these patients were found 
to be packed with infected and uninfected erythrocytes. The 
electron microscopic studies have shown the attachment of 
infected erythrocytes to the host endothelium through knobs. 
Knobs are cup shaped protuberances on the surface of parasit- 
ized erythrocytes. They contain several host and parasite de- 
rived molecules. The knob mediated cytoadherence phenome- 
non is through a recepto~ligand type of interaction. The host 
and parasite molecules involved in this interaction are reviewed 
elsewhere [1]. 
The formation of knobs has been found to be associated with 
the synthesis of knob associated histidine-rich protein 
(KAHRP)  [2]. This protein is synthesized by ring and early 
trophozoite stages of the parasite [3]. KAHRP is then trans- 
ported to the red cell membrane where it induces knobs by 
interacting with several host as well as parasite derived mole- 
cules [4]. Earlier, we have reported the cloning and sequencing 
of the KAHRP gene from a Gambian isolate FCR3 [3,5]. Here, 
we report the sequence of KAHRP gene from two Indian iso- 
lates of P falciparum, indicating that they are different. The 
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PCR data showed the presence of multiple alleles of this gene 
among Indian isolates, an indication of various P falciparum 
strains in India. 
2. Materials and methods 
2.1. Parasite isolates 
Different P falciparum isolates, adapted in culture, were obtained 
from the parasite bank of Malaria Research Centre Delhi. These iso- 
lates were from various parts of the country. The clinical samples from 
Jaisalmer, Rajasthan (North-Western India) epidemic were not 
adapted in culture. DNA from these samples was isolated irectly from 
the patient's infected blood. DNA from FCR3-Gambia nd HB3-Hon- 
dura was used as positive control 
2.2. Polymerase chain reaction 
The sequence of the primers used in PCR is as follows: Fd, 5'-CCC 
TAA CCA CAG CAT CCTG-3'; Fe, 5'-AAT AAT GGA AAC GGA 
TCC GGT GAC-3'; Ff, 5'-GTA CTG CAC TAG CTC CTG TAG 
TTG-3'; Fi, 5'-GAA ACA AAA AAC ACC GCT G-3'. To set the PCR 
reaction, 100 ng DNA was used. In this reaction mixture, 2,uM Primers, 
200 pM nucleotides, 2.5 units of Taq DNA polymerase were used. The 
DNA was denatured at 95°C for 5 min for the first time and then for 
1 min in the subsequent cycles. The primer annealing was carried out 
at 48°C for the Fd and Fe pair and 45°C for the Ff and Fi pair. The 
polymerization/DNA synthesis was carried out at 72°C for 1 min. The 
amplification was carried out for 30 cycles. After these cycles, the 
product was left for 5 min at 72°C for polymerization. The amplified 
product was analyzed on 2% agarose gel. 
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Fig. 1. PCR amplification of KAHRP gene segments from C-terminal 
domain (Region III) of P jalciparum cultured isolates from India. 
Primer set of Fi and Ff was used. The sequence of the primers are given 
in the text. Lane M, marker (50 bl>-2 kb ladder); Lane 1, no DNA; Lane 
2, Pf3 92 from Delhi; Lane 3, FCR3 from Gambia; Lane 4, HB 3 from 
Hondura; Lane 5, Pf29 92 from Delhi; Lane 6, FDL1 from Delhi; Lane 
6, clone 2 from Shankargarh; Lane 7, clone 87 from Assam; Lane 8, 
clone 89 from Orissa; lane 10, GP-30 from Ghaziabad; Lane 11, FSJA 
5 from Shahjahanpur; Lane 12, FSA from Assam: Lane 13, FSJB 6 
from Shahajahanpur; Lane 14, Rajasthan; Lane 15, human; Lane 16, 
P vivax. 
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2.3. Cloning the PCR product 
The PCR product  (~ 1.8 kb), obta ined by using pr imers Fd and  Fe, 
covers the entire main  cod ing  region o f  KAHRP gene. This f ragment  
was c loned into the PCR-scr ip t  SK(+)  plasmid.  Briefly, the PCR prod-  
uct (~ 1.8 kb  band)  was purif ied f rom agarose gel using the Q IAEX kit 
(Q iagen Inc., Chats  Worth ,  USA).  The ends of  the eluted f ragments  
were pol ished before c lon ing into the pCR script p lasmid.  The Taql and 
RsaI f ragments  o f  the KAHRP gene f rom these PCR clones were 
subc loned into the ClaI or  SmaI site o f  pGEM 3z or 7z plasmid.  
2.4. Nucleotide sequencing 
The CTAB-DNA prec ip i tat ion method was used to isolate DNA for 
nucleot ide sequencing [6]. The nucleot ide sequencing was per fo rmed on 
the double  s t randed DNA using sequenase version 2.0 (sequencing kit 
Pf3-92 C N N G N G S G D S F D F R N K R T L A Q K Q H E H H H H H H H Q H E 
Pf29-92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
FCR-3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NF7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  H -H  
35 
P~-92 H Q H Q A P H Q A x x x x H H H H H H G E V N H Q A G Q V H Q Q V H G 
P~9-92 . . . . . . . . .  x x x x  . . . . . . . . . . . . .  P . . . . . . . .  
FCR-3 . . . . . . . . .  x x x x  . . . . . . . . . . . . .  P . . . . . . . .  
N~ . . . . . . . . .  PHQA . . . . . . . . . . . . .  P 
70 
Pf3-92 Q D Q A H H H H H H H H H Q L Q P Q Q L Q G T V A N P P S N E P V V R 
Pf29-92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  K 
FCR-3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  K 






TQV I R E A R P G G G F K A Y E E K Y E  S K H Y K L K E N V V D G K  
- - - F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
- - - F . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  






K D C D E K Y E A A N Y A F  S E E C P Y T V N D Y S Q E N G P N  I FA  175 
Pf3-92 L R K R F P L G M N D E D E E G K E A L A I K D K L P G G L D E Y Q N 
Pf29-92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
FCR-3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NF-7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
210 
Pf3-92 Q L Y G I C N E T C T T C G P A T I D Y V P A D A P N G Y A Y G G S A 
Pf29-92 . . . . . . . . . . . . . . . .  A . . . . . . . . . . . . . . . . . .  
FCR-3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NF-7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
245 
Pf3-92 H D G S H G N L R G H D N K G S E G Y G Y E A P Y N P G F N G A P G S 
Pf'29-92 R . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
FCR-3 . . . . . . . . . . .  G . . . . . . . . . . . . . . . . .  
NF-7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
280 
Pf3-92 N G M Q N Y V P P H G A G Y S A P Y G V P H G A A H G S R Y S S F S S 315 
Pf29-92 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
FCR-3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NF-7 . . . . . . .  H - W S . . . . . . . . . . . . . . . . . . . . . . . .  
Fig. 2. The KAHRP sequence homology  between Ind ian  isolates (Pf3-92 and Pf29-92) ,  Gambian  isolate (FCR3)  and  Ghana isolate (NF7).  The 
common amino  acid sequences to P f  3 -92  are shown by a dash  (-) and  the delet ions are shown as cross (x). The repeat  domains  are underl ined.  The 
boxes indicate the homologous  region to erythro id  skeletal protein 4.1 which binds to host spectr in -act in .  
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P~-92 T S K E G T K E A S T S K E G T K E A S T S K G A T K E A S T T E G A 560 
T x x x x x x x x x x x x x x x x x x x x - - -  
T x  x x x x  x x x x x x  x x x x  x x xx  x - - -  
m . . . . . . . . . . . . . . . . . . . .  
Pf29-92 - - - G A 
FCR-3 - - - G A . . . .  




T KGA S T TAG S T T GAT T GANAVQ S KD G TAD KNAAN N 
E . . . . . . .  D 
NF-7 . . . . . . . . . . . . . .  
Pf3-92 G E Q V M S R G Q A Q L Q E A G K K K K K R G C C GStop 
Pf29-92 . . . . . . . . . . . . . . . . . . . . . . . . . . .  
FCR-3 . . . . . . . . . . . . . . . . . . . . . . . . . . .  
NF-7 . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Fig. 2 (continued). 
from US Biochemicals, Cleveland, USA) according their instructions. 
Mr3 universal pr imers were used to sequence the TaqI and RsaI  clones. 
The internal pr imers based on known knob protein gene sequence [5] 
were also synthesized and used for sequencing. 
2.5. EMBL accession umbers 
The accession umbers for the nucleotide sequences reported here are 
K92413 (for Pf3 92) and X92414 (for Pf29 92). 
595 
621 
3.  Resu l ts  
The knob-assoc ia ted  h i s t id ine - r i ch  pro te in  (KAHRP)  of  
P falciparum has  three  d i f fe rent  domains :  N - te rmina l  h i s t id ine -  
r ich  domain  (Reg ion  I), cent ra l  l ys ine - r i ch  domain  (Reg ion  If),  
and  C- te rmina l  decapept ide  repeats  (Reg ion  I I I )  as descr ibed  
in [5,7]. The  ampl i f i ca t ion  o f  reg ion  I I I  o f  th is  gene  was  car r ied  
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Fig. 3. PCR amplification fthe C-terminal repeats domain of KAHRP 
gene from the patients blood. These patients were suffering with falci- 
parum malaria during the epidemic n Jaisalmer, Rajasthan. Numbers 
at the top belong to the patient number. The primers were the same as 
in Fig. 1. 
out on the available cultured parasites of P falciparum from 
India. The results showed the presence of two distinct alleles 
(Fig. 1). Based on these results we decided to sequence the 
entire main coding region of both alleles. For this purpose the 
KAHRP gene from each of the two Indian isolates (Pf3 92 and 
Pf29-92) was amplified and cloned. Sequencing of 2 to 4 inde- 
pendent clones, for each allele, was carried out to rule out the 
possibility of PCR mistakes. The deduced amino acid sequence 
of both Indian isolates (Pf3-92 and Pf29-92) was compared 
with the available sequences from FCR3 (Gambia) and NF7 
(Ghana) as shown in Fig. 2 [5,8]. The histidine-rich domain of 
Indian isolates was the same as of FCR3 except at position 62 
where Proline has been replaced by glycine in Pf3-92 but not 
in Pf29-92. There were certain point mutations at scattered 
places in the gene. This has resulted in a single amino acid 
change at certain places. However, the sequences required for 
the interaction with host protein spectrin and actin (homolo- 
gous to erythroid skeletal protein 4.1) were found to be con- 
served among all the isolates (residue 318 to 330 and 347 to 355 
in Fig. 2 and ref. [4]). 
Except few minor point mutations, the first two domains 
were conserved among both the Indian isolates. The major 
differences were noticed in the C-terminus domain where Pf3- 
92 contained two extra decapeptides compared to Pf29-92. 
Therefore, in this region, Pf29 92 showed more homology to 
FCR3 whereas the Pf3-92 showed homology to NF7. The other 
major differences observed between NF7 and other isolates 
(amino acid residue 402 to 434) were due to reading frame 
change in NF7. The N-terminus histidine-rich domain of In- 
dian isolates [(His)7 - -  (His)6 - -  (His)9 ] was also different from 
NF7 [(His)]] - -  (His)6 - -  (His)~0]. The NF7 also has an extra 
tetra-peptide Pro-His-Gln-Ala in this region. 
The above mentioned observations were further extended to 
the clinical isolates of P falciparum from Rajasthan epidemic 
[9]. The PCR results showed some distinct differences among 
the clinical isolates (Fig. 3). The majority of clinical isolates 
from this North-Western State epidemic showed the PCR prod- 
uct of the same size as of Pf3-92 (~400 bp). Nevertheless, some 
individuals howed the presence of both KAHRP gene alleles 
(RJ 24 and RJ 108 in Fig. 3). We have also observed an inter- 
mediate sized band in one of patient (RJ 181) which was similar 
to HB3 from Hondura. Besides, patients having both alleles, 
only one patient (RJ 220) had the low molecular weight band 
(-340 bp), similar to pf29 92 (Fig. 3). So far, we have analyzed 
29 clinical isolates from this epidemic and found that 79% 
(23/29) had a pattern like Pf3-92 (~400 bp), 10% (3/29) had the 
mixture of Pf3-92 and Pf29-92 and one each showing the band- 
ing pattern of Pf29~2 and an intermediate like HB3, respec- 
tively. It is interesting to note that the PCR product from 
cultured isolates (Fig. 1) did not show such mixture or interme- 
diate form (compare Fig. 1 and Fig. 3). The loss of the slow 
growing strain from the mixture, during the long term parasite 
culture, cannot be ruled out at this stage. But there was no 
difference in the PCR profile of two isolates (R J24 and R J108) 
before and after one month of in vitro culture: in both cases two 
bands were observed data not shown). 
4. Discussion 
The observed variations in the KAHRP gene are mainly in 
the C-terminal peptide repeat domain whereas the other two 
domains (N-terminal and central) remained almost unaltered. 
Of these three domains, the central and C-terminal domains 
have been reported to be immunogenic in human [7]. But only 
the C-terminal domain showed variations although both have 
peptide repeats. The noticeable difference between these two 
domains is the presence of a spectrin actin binding region 
within the central domain, which is conserved among all the 
isolates (Fig. 2). This indicates that the changes in peptide 
repeats at the C-terminal domain could be allowed by the par- 
asite to evade the host immune system whereas the biologically 
important domain is still maintained unaltered uring evolu- 
tion. Although it is a difficult question to address as to which 
isolate is recently evolved. In general, the immunogenecity of 
the peptides eems to be increased with an increased number 
of repeats. Therefore, if the parasite isevading the host immune 
system for its survival (and thus more evolved) then it should 
contain more repeats. The generation of such variation is pos- 
sible due to genetic recombination. But the other isolate, having 
less peptide repeats in the C-terminal domain, being more 
evolved cannot be ruled out since deletions are more easy to 
occur. However, to retain the function of evasion of host im- 
mune system, for its survival, the parasite may opt for the 
recombination event. 
Recently three labs have independently cloned the gene for 
a highly variable knob antigen called as P falciparum erythro- 
cyte membrane protein-I (PFEMP-1) [10-12]. It has been spec- 
ulated that the C-terminal acidic domain of PFEMP-1 must be 
interacting with the positively charged KAHRP through salt 
bridges [11]. It will be interesting tomap this interacting domain 
of KAHRP to explore the possibility of its being conserved 
among different isolates of P falciparum. The complexity of the 
PFEMP-1 gene has shown the ability of the parasite to express 
a large number of variant forms of this protein; each erythro- 
cytic cycle can have a new variant of PFEMP-I. This antigenic 
variation has been correlated to the evasion of host immune 
attack by the parasite [13]. Nevertheless, the respective interact- 
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ing domains of KAHRP and PFEMP-1 must remain con- 
served. 
The antigenic variation and strain polymorphism are major 
cause of concern for malaria vaccine programmes. Raising of 
a universal malaria vaccine, therefore, has not been very suc- 
cessful. This warrants the development of alternative strategies 
such as molecular therapy, using anti-sense RNA or ribozymes. 
The KAHRP can be the best candidate for this purpose since 
it is involved in the induction of knobs [2]. The knobby para- 
sites get sequestered in deep vasculature where they are at- 
tached to host endothelium and also to normal RBCs to form 
rosettes and thereby causing pathogenecity [14,15]. Both of 
these cytoadherent phenomena re shown to be knob mediated 
[14,16]. The knobless parasites, which were produced during 
long term cultures in the lab, were found to have lost their 
virulence and the capacity to synthesize KAHRP [2,3,17-19]. 
The molecular eagents to cease the knob formation will there- 
fore be useful to treat the falciparum malaria. In this regard we 
are attempting to develop the ribozyme, based on the conserved 
KAHRP sequences. 
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